1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburg, Pennsylvania, USA
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
CD44 standard (CD44s) expression is increased in malignant prostate cancer compared to benign tissues. This suggests CD44s may serve as a biomarker for prostate cancer detection and progression.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: